Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1976 May;39(5):508–513. doi: 10.1136/jnnp.39.5.508

Chymopapain in the treatment of ruptured lumbar discs. Preliminary experience in 48 patients.

J C Maroon, R A Holst, C P Osgood
PMCID: PMC492316  PMID: 778345

Abstract

The results of chemonucleolysis in 48 patients with lumbar disc disease revealed marked improvement in 58%, slight improvement in 23%, and no improvement in 19%. Serious anaphylactic reactions occurred in two patients. These results and those of other neurosurgical and orthopaedic studies are summarized and compared with the 70% improvement rate obtained with a placebo in a recent double blind controlled cooperative study. Only those few investigators participating in the double blind study are now permitted to use intradiscal chymopapain. It is concluded that the ultimate place of chemonucleolysis, if any, in the treatment of ruptured lumbar discs remains to be determined.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. E. Clinical studies on chemonucleolysis. Clin Orthop Relat Res. 1969 Nov-Dec;67:94–99. [PubMed] [Google Scholar]
  2. Macnab I. Chapter 13. Chemonucleolysis. Clin Neurosurg. 1973;20:183–192. [PubMed] [Google Scholar]
  3. Onofrio B. M. Injection of cymopapain into intervertebral discs. Preliminary report on 72 patients with symptoms of disc disease. J Neurosurg. 1975 Apr;42(4):384–388. doi: 10.3171/jns.1975.42.4.0384. [DOI] [PubMed] [Google Scholar]
  4. Parkinson D., Shields C. Treatment of protruded lumbar intervertebral discs with chymopapain (Discase). J Neurosurg. 1973 Aug;39(2):203–208. doi: 10.3171/jns.1973.39.2.0203. [DOI] [PubMed] [Google Scholar]
  5. SMITH L. ENZYME DISSOLUTION OF THE NUCLEUS PULPOSUS IN HUMANS. JAMA. 1964 Jan 11;187:137–140. doi: 10.1001/jama.1964.03060150061016. [DOI] [PubMed] [Google Scholar]
  6. Scoville W. B., Silver D. Letter: Results of Scoville and Silver's questionnaire on chymopapain. J Neurosurg. 1975 Apr;42(4):487–487. [PubMed] [Google Scholar]
  7. Shealy C. N. Tissue reactions to chymopapain in cats. J Neurosurg. 1967 Mar;26(3):327–330. doi: 10.3171/jns.1967.26.3.0327. [DOI] [PubMed] [Google Scholar]
  8. Sussman B. J. Inadequacies and hazards of chymopapain injections as treatment for intervertebral disc disease. J Neurosurg. 1975 Apr;42(4):389–396. doi: 10.3171/jns.1975.42.4.0389. [DOI] [PubMed] [Google Scholar]
  9. Watts C., Hutchison G., Stern J., Clark K. Comparison of intervertebral disc disease treatment by chymopapain injection and open surgery. J Neurosurg. 1975 Apr;42(4):397–400. doi: 10.3171/jns.1975.42.4.0397. [DOI] [PubMed] [Google Scholar]
  10. Watts C., Knighton R., Roulhac G. Chymopapain treatment of intervertebral disc disease. J Neurosurg. 1975 Apr;42(4):374–383. doi: 10.3171/jns.1975.42.4.0374. [DOI] [PubMed] [Google Scholar]
  11. Wiltse L. L., Rocchio P. D. Preoperative psychological tests as predictors of success of chemonucleolysis in the treatment of the low-back syndrome. J Bone Joint Surg Am. 1975 Jun;57(4):478–483. [PubMed] [Google Scholar]
  12. Wiltse L. L., Widell E. R., Jr, Yuan H. A. Chymopapain chemonucleolysis in lumbar disk disease. JAMA. 1975 Feb 3;231(5):474–479. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES